Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer
Guang Yang et al.
ONCOLOGY REPORTS (2021)
The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6
Sharleen V. Menezes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Characterization of the prognostic values of the NDRG family in gastric cancer
Chaoran Yu et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells
L. Mi et al.
ONCOGENE (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann et al.
LANCET ONCOLOGY (2014)
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Harpreet Wasan et al.
LANCET ONCOLOGY (2014)
The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways
Zaklina Kovacevic et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells
K. M. Dixon et al.
BRITISH JOURNAL OF CANCER (2013)
Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors
Jing Sun et al.
CARCINOGENESIS (2013)
Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
Jing Sun et al.
MOLECULAR PHARMACOLOGY (2013)
Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane
Leiliane P. Sousa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Regulation of the EGF Transcriptional Response by Endocytic Sorting
Ben Brankatschk et al.
SCIENCE SIGNALING (2012)
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Toni M. Brand et al.
CANCER BIOLOGY & THERAPY (2011)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications
Veerle Melotte et al.
FASEB JOURNAL (2010)
Evolving Treatment of Advanced Colorectal Cancer
Andrea Cercek et al.
CURRENT ONCOLOGY REPORTS (2010)
Cetuximab/C225-Induced Intracellular Trafficking of Epidermal Growth Factor Receptor
Hong-Jun Liao et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study
Chiew-Loon Koo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation
Sara Sigismund et al.
DEVELOPMENTAL CELL (2008)
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
D. L. Wheeler et al.
ONCOGENE (2008)
Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network
Sandra Morandell et al.
PROTEOMICS (2008)
p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis
David Teis et al.
JOURNAL OF CELL BIOLOGY (2006)
The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer
Zaklina Kovacevic et al.
CARCINOGENESIS (2006)
Clathrin-independent endocytosis of ubiquitinated cargos
S Sigismund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation
LM Grovdal et al.
EXPERIMENTAL CELL RESEARCH (2004)
Clathrin-mediated endocytosis in AP-2-depleted cells
A Motley et al.
JOURNAL OF CELL BIOLOGY (2003)
Share Paper
